Newsfeed

There is hope for those with PH
When Joan Nemeth could not climb stairs or vacuum her living room without getting out of breath, she knew something was seriously wrong. Diagnosed five years ago with pulmonary hypertension, the Vernon resident was a non-smoker who had always enjoyed good health. “I had no idea what it was, but I was under a doctor’s care and I expected a diagnosis,” she said. “One morning I woke up and I could not make it to the bathroom because I couldn’t…
PH Awareness at the Leisure Centre
Pulmonary Hypertension is a rare, debilitating, progressive and potentially fatal disease, affecting up to 10,000 Canadians – although it’s hard to know for certain. Early symptoms are so general, that they are often misdiagnosed by attending physicians. Breathlessness, fatigue, irregular heartbeat, fainting, chest pain – the signs of PH may be interpreted as anything from a heart condition, to Asthma. In Pulmonary Hypertension, the arterie…
Novel Surgical CTEPH Treatment Approach Cures Disease
Vanderbilt Heart & Vascular Institute (VHVI) is offering a novel and specialized surgical approach for treating patients suffering from chronic thromboembolic pulmonary hypertension (CTEPH), a form of pulmonary hypertension (PH) that can cause breathing difficulties, acute pulmonary embolism, or blood clots in the lung. Even though the condition is rare and often misdiagnosed, several efforts have been made to support patients, including the crea…
Magnetic resonance imaging may aid detection of pulmonary hypertension
1. Among patients with suspected pulmonary artery hypertension, vortical blood flow measurement by magnetic resonance (MR) imaging agreed closely with direct pressure measurement by during right heart catheterization. 2. The duration of vortical blood flow corresponded linearly with the degree of pulmonary artery hypertension and served as a specific and non-invasive method for its detection. Evidence rating: 3 (Average) Study Rundown: P…
PH Research Corner: Developing Novel Therapies for Pulmonary Arterial Hypertension.
In this corner, you will find the latest advancements in the field of PAH therapeutics. But before we get into that, I think it would be useful to start with information on how new therapies are tested before getting to the patients. The process starts with a screen of different chemicals. In PAH, we know that cells in blood vessels in the lungs are hyper-proliferative, meaning that they multiply too quickly, very similarly to a cancerous cell…
Navigating caregiving, chronic conditions a strain on Canadians, according to new survey
For many Canadians, finding their way through the healthcare system is a daunting task. In fact, 81 per cent of Canadians find the system too complicated, and 78 per cent agree that navigating it is a challenge, according to a recent survey commissioned by CARP and the Sheridan Centre for Elder Research, and made possible by Amgen Canada. When asked what presents the biggest challenges to navigating the system, Canadians identified management of …
New PAH Research Highlights Importance of Exercise
Exercise and fitness are two health factors that invariably affect prognoses for most chronic, progressive diseases. Given the stress and immobility that come as a result of illness, maintaining fitness to the best of the patient’s ability is generally a best practice for maximizing quality of life and lifespan. However, new PAH research suggests that patients’ muscles are affected by the disease at the cellular level, and that any measure of exe…
Freeze-dried plants may treat pulmonary hypertension
A drug grown in plant leaves and then freeze dried and enclosed in capsules might offer a much-needed treatment for pulmonary hypertension, a disease for which few therapy options exist. When rats with established pulmonary hypertension were treated with plant-delivered medication for two weeks, their pulmonary pressure was reduced by 20 percent. After four weeks, pulmonary pressure was reduced by 32 percent. RELATED ARTICLES ON FUTURITY …
Quebec breathes new hope into lives of those affected by pulmonary arterial hypertension
Patients elsewhere in Canada hope for swift access to new treatment option now funded in Quebec VANCOUVER, Oct. 8, 2014 /CNW/ - The Pulmonary Hypertension Association of Canada (PHA Canada) was pleased to learn that a new treatment option for pulmonary arterial hypertension (PAH) is now being publicly funded in the province of Quebec. On October 1, the Institut national d'excellence en santé et services sociaux (INESSS) recommended that the dr…
Noninvasive diagnosis ‘reliable’ for pulmonary hypertension diagnosis
medwireNews: Doppler echocardiography has good accuracy relative to right heart catheterisation for detecting pulmonary hypertension, shows a large study. The study involved 1695 patients at a single cardiac care centre who underwent Doppler echocardiography no more than 5 days before or after right heart catheterisation. Researcher Sebastian Greiner (University of Heidelberg, Germany) and team say that their study is considerably larger th…
Recent News

Subscribe

Get the latest on PH treatments, community events and more when you subscribe to our newsletter

ImagineCan_Accreditation_Trustmark_ENGFR_WHT-FNL_white.png